These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1181 related articles for article (PubMed ID: 16153868)

  • 1. VISA is an adapter protein required for virus-triggered IFN-beta signaling.
    Xu LG; Wang YY; Han KJ; Li LY; Zhai Z; Shu HB
    Mol Cell; 2005 Sep; 19(6):727-40. PubMed ID: 16153868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIKE is an IKK epsilon/TBK1-associated suppressor of TLR3- and virus-triggered IRF-3 activation pathways.
    Huang J; Liu T; Xu LG; Chen D; Zhai Z; Shu HB
    EMBO J; 2005 Dec; 24(23):4018-28. PubMed ID: 16281057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of IRF-3 and IRF-7 phosphorylation following activation of the RIG-I pathway.
    Paz S; Sun Q; Nakhaei P; Romieu-Mourez R; Goubau D; Julkunen I; Lin R; Hiscott J
    Cell Mol Biol (Noisy-le-grand); 2006 May; 52(1):17-28. PubMed ID: 16914100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR3/TRIF signalling pathway regulates IL-32 and IFN-β secretion through activation of RIP-1 and TRAF in the human cornea.
    Park GB; Hur DY; Kim YS; Lee HK; Yang JW; Kim D
    J Cell Mol Med; 2015 May; 19(5):1042-54. PubMed ID: 25754842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.
    Jiang Z; Mak TW; Sen G; Li X
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3533-8. PubMed ID: 14982987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RACK1 attenuates RLR antiviral signaling by targeting VISA-TRAF complexes.
    Xie T; Chen T; Li C; Wang W; Cao L; Rao H; Yang Q; Shu HB; Xu LG
    Biochem Biophys Res Commun; 2019 Jan; 508(3):667-674. PubMed ID: 30527812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus.
    Meylan E; Curran J; Hofmann K; Moradpour D; Binder M; Bartenschlager R; Tschopp J
    Nature; 2005 Oct; 437(7062):1167-72. PubMed ID: 16177806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression.
    Kaukinen P; Sillanpää M; Kotenko S; Lin R; Hiscott J; Melén K; Julkunen I
    Virol J; 2006 Sep; 3():66. PubMed ID: 16945160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAK-associated protein 1 participates in both the TLR3 and the cytoplasmic pathways in type I IFN induction.
    Sasai M; Shingai M; Funami K; Yoneyama M; Fujita T; Matsumoto M; Seya T
    J Immunol; 2006 Dec; 177(12):8676-83. PubMed ID: 17142768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct binding of TRAF2 and TRAF6 to TICAM-1/TRIF adaptor participates in activation of the Toll-like receptor 3/4 pathway.
    Sasai M; Tatematsu M; Oshiumi H; Funami K; Matsumoto M; Hatakeyama S; Seya T
    Mol Immunol; 2010 Mar; 47(6):1283-91. PubMed ID: 20047764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta.
    Oshiumi H; Sasai M; Shida K; Fujita T; Matsumoto M; Seya T
    J Biol Chem; 2003 Dec; 278(50):49751-62. PubMed ID: 14519765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DEAH-box RNA helicase DHX15 activates NF-κB and MAPK signaling downstream of MAVS during antiviral responses.
    Mosallanejad K; Sekine Y; Ishikura-Kinoshita S; Kumagai K; Nagano T; Matsuzawa A; Takeda K; Naguro I; Ichijo H
    Sci Signal; 2014 Apr; 7(323):ra40. PubMed ID: 24782566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRAF6 establishes innate immune responses by activating NF-kappaB and IRF7 upon sensing cytosolic viral RNA and DNA.
    Konno H; Yamamoto T; Yamazaki K; Gohda J; Akiyama T; Semba K; Goto H; Kato A; Yujiri T; Imai T; Kawaguchi Y; Su B; Takeuchi O; Akira S; Tsunetsugu-Yokota Y; Inoue J
    PLoS One; 2009 May; 4(5):e5674. PubMed ID: 19479062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A20 is a potent inhibitor of TLR3- and Sendai virus-induced activation of NF-kappaB and ISRE and IFN-beta promoter.
    Wang YY; Li L; Han KJ; Zhai Z; Shu HB
    FEBS Lett; 2004 Oct; 576(1-2):86-90. PubMed ID: 15474016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HAUS8 regulates RLR‑VISA antiviral signaling positively by targeting VISA.
    He TS; Chen T; Wang DD; Xu LG
    Mol Med Rep; 2018 Aug; 18(2):2458-2466. PubMed ID: 29916539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase Calpha is involved in interferon regulatory factor 3 activation and type I interferon-beta synthesis.
    Johnson J; Albarani V; Nguyen M; Goldman M; Willems F; Aksoy E
    J Biol Chem; 2007 May; 282(20):15022-32. PubMed ID: 17296604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ECSIT bridges RIG-I-like receptors to VISA in signaling events of innate antiviral responses.
    Lei CQ; Zhang Y; Li M; Jiang LQ; Zhong B; Kim YH; Shu HB
    J Innate Immun; 2015; 7(2):153-64. PubMed ID: 25228397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock cognate 71 (HSC71) regulates cellular antiviral response by impairing formation of VISA aggregates.
    Liu Z; Wu SW; Lei CQ; Zhou Q; Li S; Shu HB; Wang YY
    Protein Cell; 2013 May; 4(5):373-82. PubMed ID: 23636689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus X protein suppresses virus-triggered IRF3 activation and IFN-beta induction by disrupting the VISA-associated complex.
    Wang X; Li Y; Mao A; Li C; Li Y; Tien P
    Cell Mol Immunol; 2010 Sep; 7(5):341-8. PubMed ID: 20711230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
    Yamamoto M; Sato S; Mori K; Hoshino K; Takeuchi O; Takeda K; Akira S
    J Immunol; 2002 Dec; 169(12):6668-72. PubMed ID: 12471095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.